https://jualslotcaramasakg.wixsite.com/pantrymagic Slot Gacor Gampang Menang Situs Slot Gacor https://gms.dpe.go.th/mobile/public/admin/ckfinder/plugins/fileeditor/situs-judi-slot-terbaik-dan-terpercaya-no-1/ https://geokur-dmp.geo.tu-dresden.de/uploads/user/2022-12-12-182312.459691situs-slot-gacor.html https://geokur-dmp.geo.tu-dresden.de/uploads/user/2022-12-12-183122.222613slot-gacor-gampang-menang.html http://www.digi.vibeunited.co.id/forum/profile/bocoran-slot-gacor-hari-ini/ https://cungtenhanoi.com/2022/12/30/bocoran-pola-jam-hoki-main-slot-gacor-hari-ini-terbaru-gampang-menang-jackpot-terbesar-2022/
Business

Ferrari, Apple, KB Home and more




Signs are posted in front of homes under construction at a KB Home housing development on January 12, 2022 in Novato, California.

Justin Sullivan | Getty Images

Take a look at the companies making the biggest moves in premarket trading:

Ferrari — Shares of the luxury automaker rose less than 1% early Monday after Morgan Stanley analyst Adam Jonas named it a top pick, replacing Tesla. In a note to clients, Jonas cited Ferrari’s backlog and price strength as reasons for raising the price target on the stock by more than 10%.

apple — The iPhone maker advanced 2% premarket after Goldman Sachs initiated coverage with a buy rating, saying Apple could get a big boost from its services business. The Wall Street bank’s 12-month price target of $199 suggests Apple could rise more than 30% from here.

KB Home — The homebuilder fell 1.4% after a double downgrade to underweight from overweight by JPMorgan. The firm cited the stock’s expensive valuation.

DR Horton — DR Horton, another homebuilder, fell a little more than 1% after it was downgraded by JPMorgan to neutral from overweight. Analysts said the stock’s premium valuation fairly reflected its above-average fundamental profile and expect the stock to perform only in line with its peers.

Vir Biotechnology — The biotech rose 5% after JPMorgan upgraded it to overweight from neutral. The bank said Vir has long-term pipeline opportunities across a range of disease indications.

Silvergate capital — The bank continued its decline and fell around 8% pre-market. Last week, Silvergate Capital warned about its ability to continue as a going concern and delayed the filing of its annual report.

— CNBC’s Yun Li and Jesse Pound contributed reporting.



Source link

Back to top button